ArcherDX

ArcherDX, Inc. is a genomics company based in Boulder, Colorado, that specializes in the development and commercialization of products for genetic analysis, particularly in oncology. The company offers a range of research-use-only products, including DNA-based VariantPlex, RNA-based FusionPlex, and ctDNA-based LiquidPlex, which are designed for genomic analysis aimed at therapy optimization and cancer monitoring. ArcherDX employs a proprietary technology platform using Anchored Multiplexed PCR (AMP™) chemistry and bioinformatics software to enhance the detection of genetic mutations and fusions through next-generation sequencing. Additionally, the company provides assay design services, allowing clinical and biopharmaceutical customers to customize biomarker targets. ArcherDX's products and services cater to academic and reference laboratories, biopharmaceutical companies, and contract research organizations. Founded in 2013, ArcherDX operates as a subsidiary of Invitae Corporation and is pursuing regulatory approval for various companion diagnostic assays.